Deferoxamine News and Research

RSS
Deferoxamine is a chelating agent used to remove excess iron from the body.
Early human testing of iron chelation after brain bleed shows mixed results

Early human testing of iron chelation after brain bleed shows mixed results

Exploiting rabies virus machinery to usher Parkinson's disease drug directly to the brain

Exploiting rabies virus machinery to usher Parkinson's disease drug directly to the brain

Researchers identify specific pathways involved in development of mucormycosis

Researchers identify specific pathways involved in development of mucormycosis

Study provides insight into the mechanisms underlying diabetic peripheral neuropathy

Study provides insight into the mechanisms underlying diabetic peripheral neuropathy

IOF Young Investigator Awards presented to five researchers at 4th Asia-Pacific Osteoporosis Meeting

IOF Young Investigator Awards presented to five researchers at 4th Asia-Pacific Osteoporosis Meeting

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

ODAC recommends ApoPharma's Ferriprox for FDA approval to treat transfusional iron overload

ODAC recommends ApoPharma's Ferriprox for FDA approval to treat transfusional iron overload

New data demonstrating the strength of Novartis' hematology portfolio to be presented

New data demonstrating the strength of Novartis' hematology portfolio to be presented

APP Pharmaceuticals announces FDA marketing approval of Deferoxamine Mesylate

APP Pharmaceuticals announces FDA marketing approval of Deferoxamine Mesylate

Deferoxamine could help diabetics heal wounds

Deferoxamine could help diabetics heal wounds

Drug deferoxamine boosts bone healing and re-growth

Drug deferoxamine boosts bone healing and re-growth

New drug may revolutionize how chronic iron overload is treated in chronic anemia patients

New drug may revolutionize how chronic iron overload is treated in chronic anemia patients